CA-THERMO-FISHER
31.5.2024 08:01:28 CEST | Business Wire | Press release
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic Regulations (IVDR) 2017/746 in the European Union. These compliance updates will enable cytogenetics testing laboratories to adapt to the latest medical device safety and efficacy frameworks and conformity assessments.
“Thermo Fisher’s unparalleled commitment to driving innovation in chromosomal microarrays has led to advancement of cytogenetic testing capabilities,” said Kevin Lowitz, vice president and general manager, microarray, at Thermo Fisher Scientific. “The compliance updates to the CytoScan Dx Assay kit and ChAS Dx software provide our customers in the EU with solutions that can help them maintain high patient safety standards and meet EU IVD regulatory requirements.”
Advancements in chromosomal microarrays (CMAs) have greatly expanded the capabilities of cytogenetics testing in recent years, including the ability to yield insights into genetic risk factors and disorders that are essential to understanding reproductive health. As an in vitro diagnostic CMA test for postnatal analysis, the CytoScan Dx Assay aids in the identification of underlying genetic causes of neurological and dysmorphic disorders in children. The assay enables users to accurately detect numerous chromosomal variations at higher resolution and greater coverage than conventional methods. It has demonstrated to improve diagnostic yield by an incremental 12.5% compared to G-banded karyotyping.
ChAS Dx is a powerful, intuitive software that simplifies cytogenetic analysis, visualization, and reporting of chromosomal aberrations across the genome. ChAS Dx provides whole-genome support for CytoScan Dx Arrays with flexible parameters and data formats, as well as direct access to multiple leading external genetic databases. The advanced data analysis software is available to all CytoScan Dx customers at no additional cost.
The complete IVDR compliant CytoScan Dx Cytogenetics Suite is a sample to insight solution that includes the CytoScan Dx Array, a reagent kit, the Applied Biosystems™ GeneChip™ System 3000 Dx platform for array processing, and user-friendly ChAS Dx software.
To learn more about the complete IVDR compliant CytoScan Cytogenetics Suite, please visit www.thermofisher.com/microarrayivd.
For In Vitro Diagnostic Use.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of more than $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240530659960/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons enters into €500 million SACE-backed term loan facility28.7.2026 13:30:00 CEST | Press release
Bending Spoons S.p.A. (NASDAQ: BSP) announced today that it has entered into a new €500 million medium-long-term financing provided by HSBC Continental Europe (acting as Sole Coordinator and MLA), Intesa Sanpaolo S.p.A. (acting as SACE Agent and MLA), and BPER Banca Corporate & Investment Banking (acting as Structuring Advisor and MLA). The facility, which matures in March 2031, benefits from a guarantee provided by SACE, in advancement of SACE’s mission to support the international growth of Italian businesses. Together with €495 million of additional term loan A financing and a €490 million increase in commitments under Bending Spoons’ revolving credit facility, the transaction brings the aggregate amount of new and expanded facilities agreed by Bending Spoons from the beginning of the second quarter to €1.49 billion. Both the term loan A financing and the additional revolving credit facility commitments are available for general corporate purposes and acquisitions, with each of the
Promega Achieves 100% Renewable Electricity Across Global Operations28.7.2026 13:00:00 CEST | Press release
Sustainability accomplishments announced in life sciences company's 2026 Corporate Responsibility Report Promega Corporation today released its 2026 Corporate Responsibility Report, detailing significant environmental and social progress across its global operations. The report marks three milestones for the company: achievement of 100% renewable electricity across all global operations, the completion of a comprehensive value chain emissions inventory and validation of near-term emissions reduction targets by the Science Based Targets initiative (SBTi). “Our 100% renewable electricity reflects years of deliberate investment, from solar arrays on the Madison campus to renewable partnerships in the communities where we operate,” says Corey Meek, Promega Global Sustainability Manager. “Looking forward, we will continue working to strategically reduce the environmental impact of our global business.” Promega recently completed its first comprehensive greenhouse gas inventory across its gl
Lenovo Powers Esports World Cup 2026 as a Founding Partner28.7.2026 11:00:00 CEST | Press release
Lenovo™ joins EWC 2026 as a Global Partner with expanded integration across competition technology at the world’s largest esports eventLenovo Legion™ desktop PCs and monitors will equip players, broadcast operations, training facilities, and festival experiences throughout Paris this summerFans can experience the latest Legion innovations, including the Legion Pro Rollable Concept, during the seven-week competition The Esports Foundation (EF) and Lenovo today announced an expanded partnership, with Lenovo becoming a Global Partner of the Esports World Cup 2026 (EWC) and powering the world’s largest esports event with its high-performance Legion gaming devices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712251027/en/ The EWC 2026 will be bringing the world’s largest esports event to Paris for the first time, welcoming more than 2,000 players, 200 esports teams and fans from over 100 countries between July 6 and August
Ten Finalists Announced for the Reply AI Film Festival, the International Competition Bringing Together Cinema and Artificial Intelligence28.7.2026 10:00:00 CEST | Press release
The jury, chaired by Gabriele Salvatores, will announce the winners in Venice on Sunday, 6 September. The Reply AI Film Festival returns for its third edition, reaffirming its role as a meeting point for cinema, creativity and artificial intelligence. The international competition created by Reply – open to creatives experimenting with new AI technologies and tools in the production of short films – has announced its ten finalists. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728146486/en/ The international competition created by Reply – open to creatives experimenting with new AI technologies and tools in the production of short films – has announced its ten finalists. The festival will take place in Veniceduring the days of the 83rd Venice International Film Festival of La Biennale di Venezia. Selected from more than 3,000 short films submitted from 76 countries, the finalist works will take centre stage at the awards
USHIO Industry & Entertainment Announces Trademark Licensing Agreement for OSRAM-Branded Professional Technical Lighting Products28.7.2026 08:30:00 CEST | Press release
Agreement ensures continuity for customers while supporting USHIO Industry & Entertainment's business strategy USHIO Industry & Entertainment (USHIO INE) today announced the signing of a trademark licensing agreement with ams OSRAM, that enables the company to continue offering designated professional technical lighting products under the trusted OSRAM product brand. The agreement marks an important milestone following USHIO's acquisition of the former OSRAM Entertainment & Industry business and reinforces the company's commitment to ensuring continuity for customers, products and long-standing partnerships worldwide. For customers, the agreement provides continuity for professional technical lighting products that have earned a strong reputation across entertainment, cinema, industrial and other specialty lighting applications. These products will continue to be supported by USHIO Industry & Entertainment's global organization, technical expertise and customer service. "The signing of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom